In support of this the anti-epileptic sodium valproate, which has pan-HDAC inhibitory properties, reduced atherosclerosis in a rabbit model, and epidemiological studies have reported that sodium valproate is associated with reduced stroke risk compared with other anti-epileptic drugs (13). This evidence concerns the gene HDAC9 and atherosclerosis.